Nationwide Survey of Drug-Resistant Tuberculosis in the United States

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 9, 1994, Pages 665-671

  Bloch, Alan B ^a   Cauthen, George M ^a   Onorato, Ida M ^a   Dansbury, Kenneth G ^a   Kelly, Gloria D ^a   Driver, Cynthia R ^a   Snider, Dixie E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEMOGRAPHY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS; UNITED STATES;

EID: 0027979714     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510330043032     Document Type: Article

References (46)

1. Beck-Sagué C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA. 1992;268:1280-1286.
2. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
3. Centers for Disease Control. Nosocomial transmission of multidrug resistant tuberculosis among HIV-infected persons—Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991; 40:585-591.
4. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med. 1992;117:191-196.
5. Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr. Multidrug-resistant tuberculosis. Ann Intern Med. 1992;117:257-259.
6. Jereb J, Dooley S, Klevens R, et al. Nosocomial transmission of multidrug-resistant tuberculosis to health care workers, New York City. In: Program and abstracts of the World Congress on Tuberculosis; November 16-19, 1992; Bethesda, Md. Abstract 51-A.
7. Coronado VG, Beck-Sagué CM, Hutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-1055.
8. Ikeda R, Birkhead G, Di Ferdinando G, Bornstein D, Morse D. Nosocomial transmission of multidrug-resistant tuberculosis, New York. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11-14, 1992. Anaheim, Calif. Abstract 1199.
9. Coronado VG, Valway SE, Ihle W, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among intravenous drug users with HIV infection in an urban hospital. In: Program and abstracts of the World Congress on Tuberculosis; November 16-19, 1992; Bethesda, Md. Abstract 49-D.
10. Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system— New York, 1991. MMWR Morb Mortal Wkly Rep. 1992;41:507-509.
11. Valway SE, Richards SB, Kovacovich J, Greifinger RB, Crawford JT, Dooley SW. Outbreak of multidrug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol. In press.
12. Valway SE, Greifinger RB, Papania M, et al. Multidrug resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis. In press.
13. Kent JH. The epidemiology of multidrug-resistant tuberculosis in the United States. Med Clin North Am. 1993;77:1391-1409.
14. Ussery XT, Bierman JA, Valway SE, Di Ferdinando GT, Ostroff SM. Transmission of multidrug resistant Mycobacterium tuberculosis among persons exposed at a medical examiner's of fice. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11-14, 1992; Anaheim, Calif. Abstract 556.
15. American Thoracic Society/Centers for Disease Control. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis. 1986;134:355-363.
16. Jereb JA, Kelly GD, Dooley SW, Cauthen GM, Snider DE Jr. Tuberculosis morbidity in the United States: final data, 1990. In: CDC Surveillance Summaries, December 1991. MMWR Morb Mortal Weekly Rep. 1991;40(SS-3):23-27.
17. Kopanoff DE, Snider DE Jr, Johnson M. Recurrent tuberculosis: why do patients develop disease again? a United States Public Health Service Cooperative Survey. Am J Public Health. 1988;78: 30-33.
18. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, Version, 5: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, Ga: Centers for Disease Control; 1990.
19. Centers for Disease Control. National action plan to combat multidrug-resistant tuberculosis. MWWR Morb Mortal Wkly Rep. 1992;41(RR-11): 1-48.
20. Centers for Disease Control. Meeting the challenge of multidrug-resistant tuberculosis: summary of a conference. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-11):49-57.
21. Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993;31:767-770.
22. Kopanoff DE, Kilburn JO, Glassroth JL, Snider DE Jr, Farer LS, Good RC. A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. Am Rev Respir Dis. 1978;118:835-842.
23. Centers for Disease Control. Primary resistance to antituberculosis drugs—United States. MMWR Morb Mortal Wkly Rep. 1980;29:345-346.
24. Centers for Disease Control. Primary resistance to antituberculosis drugs—United States. MMWR Morb Mortal Wkly Rep. 1983;32:521-523.
25. Snider DE Jr, Cauthen GM, Farer LS, et al. Drug-resistant tuberculosis. Am Rev Respir Dis. 1991;144:732.
26. Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med. 1989;10:341-353.
27. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA. 1993;270:65-68.
28. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993;329:784-791.
29. Mitchison DA. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985; 66:219-225.
30. Davidson PT. Drug resistance and the selection of therapy for tuberculosis. Am Rev Respir Dis. 1987;136:255-257.
31. Barnes PF. The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis. 1987;136:325-328.
32. American Thoracic Society/Centers for Disease Control. Control of tuberculosis in the United States. Am Rev Respir Dis. 1992;146:1623-1633.
33. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1993;42(RR-7):1-8.
34. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it. N Engl J Med. 1993;328:576-578.
35. Nardell EA. Beyond four drugs: public health policy and the treatment of the individual patient with tuberculosis. Am Rev Respir Dis. 1993;148:2-5.
36. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE Jr. Tuberculosis in the United States. JAMA. 1989;262:385-389.
37. US Congress, Of Fice of Technology Assessment. The Continuing Challenge of Tuberculosis. Washington, DC: US Government Printing Of Fice; September 1993. Publication OTA-H-574.
38. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328: 527-532.
39. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
40. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science. 1992;257: 1055-1064.
41. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745-749.
42. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis. 1991;144:741-742.
43. Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep. 1989;38 (suppl S-3): 1-25.
44. Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HHIV-related issues. MMWR Morb Mortal WWkly Rep. 1990;39 ((RR-17):1-29.
45. Centers for Disease Control and Prevention. Tuberculosis morbidity—United States, 1992. MMWR MMorb Mortal Wkly Rep. 11993;42:696-6697,703-704.
46. Centers for Disease Control. Management of persons exposed to mmultidrug-resistantttuberculosis. MMWR Morb Mortal Wkly Rep. 11992;41(RR-111):59-71